News Ascentage raises $126m in first biotech IPO of 2025 China's Ascentage completes the first US biotech IPO of 2025, raising $126m for its pipeline of small-molecule cancer drugs.
Patients Deliver prevention at scale, PA Consulting’s James Davis James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
